Overview

Guanfacine Treatment for Prefrontal Cognitive Dysfunction in Elderly Subjects

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This proposal aims to determine whether low does of the alpha-2A-adrenoceptor agonist guanfacine can improve deficits in prefrontally-mediated cognitive functions in healthy elderly subjects.
Phase:
N/A
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute on Aging (NIA)
Treatments:
Guanfacine